Janus Henderson Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$414K Hold
33,756
﹤0.01% 2035
2025
Q1
$731K Hold
33,756
﹤0.01% 1769
2024
Q4
$766K Hold
33,756
﹤0.01% 1817
2024
Q3
$613K Hold
33,756
﹤0.01% 1932
2024
Q2
$982K Sell
33,756
-349
-1% -$10.2K ﹤0.01% 1629
2024
Q1
$1.21M Hold
34,105
﹤0.01% 1543
2023
Q4
$1.49M Sell
34,105
-63
-0.2% -$2.75K ﹤0.01% 1410
2023
Q3
$1.31M Sell
34,168
-8
-0% -$306 ﹤0.01% 1419
2023
Q2
$1.41M Sell
34,176
-1,669,911
-98% -$68.7M ﹤0.01% 1431
2023
Q1
$97.8M Sell
1,704,087
-933,972
-35% -$53.6M 0.06% 252
2022
Q4
$148M Sell
2,638,059
-3,707,017
-58% -$208M 0.11% 193
2022
Q3
$269M Buy
6,345,076
+3,064,928
+93% +$130M 0.1% 199
2022
Q2
$177M Sell
3,280,148
-2,744
-0.1% -$148K 0.12% 185
2022
Q1
$211M Sell
3,282,892
-465,392
-12% -$29.9M 0.1% 199
2021
Q4
$251M Sell
3,748,284
-395,441
-10% -$26.5M 0.1% 199
2021
Q3
$284M Sell
4,143,725
-499,344
-11% -$34.2M 0.12% 185
2021
Q2
$317M Sell
4,643,069
-14,094
-0.3% -$962K 0.14% 178
2021
Q1
$322M Buy
4,657,163
+35,000
+0.8% +$2.42M 0.15% 164
2020
Q4
$300M Buy
4,622,163
+572,291
+14% +$37.2M 0.14% 163
2020
Q3
$191M Sell
4,049,872
-145,314
-3% -$6.86M 0.1% 210
2020
Q2
$197M Sell
4,195,186
-110,740
-3% -$5.2M 0.11% 194
2020
Q1
$192M Sell
4,305,926
-6,921
-0.2% -$309K 0.13% 168
2019
Q4
$251M Buy
4,312,847
+1,086,385
+34% +$63.3M 0.13% 184
2019
Q3
$194M Sell
3,226,462
-22,408
-0.7% -$1.35M 0.11% 210
2019
Q2
$181M Buy
3,248,870
+375,546
+13% +$21M 0.1% 234
2019
Q1
$160M Buy
2,873,324
+688,761
+32% +$38.4M 0.09% 267
2018
Q4
$98.5M Buy
2,184,563
+175,432
+9% +$7.91M 0.06% 348
2018
Q3
$132M Buy
2,009,131
+42,790
+2% +$2.82M 0.07% 325
2018
Q2
$127M Buy
1,966,341
+365,254
+23% +$23.5M 0.07% 331
2018
Q1
$88.6M Sell
1,601,087
-2,665
-0.2% -$147K 0.05% 397
2017
Q4
$76.8M Sell
1,603,752
-431,536
-21% -$20.7M 0.05% 429
2017
Q3
$103M Sell
2,035,288
-20,625
-1% -$1.04M 0.07% 355
2017
Q2
$112M Buy
+2,055,913
New +$112M 0.08% 325